JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Newspaper Publication of Detailed Public Statement in connection with the open offer
JBCHEPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Torrent Pharmaceuticals Limited has launched a mandatory open offer to acquire up to 4.17 crore equity shares (26% of the expanded share capital) of JB Chemicals & Pharmaceuticals Limited at ₹1,639.18 per share, aggregating to approximately ₹6,843 crore in total consideration (assuming full acceptance). The offer is triggered by underlying Share Purchase Agreements (SPA1 and SPA2) signed on June 29, 2025, with the public announcement made the same day and this Detailed Public Statement published on July 4, 2025 in Financial Express, Jansatta, and Navshakti. The schedule indicates tendering opens around August 5, 2025 and closes around September 3, 2025, subject to statutory approvals including CCI clearance. JB Chemicals reported FY25 revenue of ₹3,956 crore and net income of ₹659 crore, while the acquirer Torrent Pharma reported FY25 revenue of ₹11,516 crore and net income of ₹1,911 crore.
This is a significant takeover event — shareholders of JB Chemicals can tender their shares at the offer price of ₹1,639.18 if they choose to exit. The offer price may act as a price floor for the stock in the near term, and successful completion would give Torrent Pharma a substantial controlling stake in JB Chemicals.